Theodore T. Wang, Director, 10% Owner at Bellerophon Therapeutics, Inc. (BLPH), bought 43,280 shares at $0.61 ($26K) on 2019-05-21, disclosed to the SEC on 2019-05-22.
Open-market purchase of $26k BLPH by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BLPH | BUY | 2019-06-14 | $32K | — | Filing → |
| BLPH | BUY | 2019-05-24 | $17K | — | Filing → |
| BLPH | BUY | 2019-01-25 | $315K | — | Filing → |